Taken together, these findings suggest a continuous spectrum of PRPS1 disease features, where hearing loss, peripheral neuropathy, optic atrophy, ataxia, cognitive deficits and recurrent infections are central, yet variable phenotypic features. This evidence concerns the gene PRPS1 and optic atrophy.